Iasis Molecular
Spokane-based software company, Iasis Molecular Sciences & Novion Technologies, innovates cost-effective antimicrobial technologies to combat healthcare-acquired infections and promote healing.
Founded
2008Spokane-based software company, Iasis Molecular Sciences & Novion Technologies, innovates cost-effective antimicrobial technologies to combat healthcare-acquired infections and promote healing.
Iasis Molecular focuses on developing innovative chemistries to address human health and habitat challenges. The company specializes in creating solutions to impede the transmission of bacterial, fungal, and viral diseases, with a particular emphasis on combating healthcare-associated infections. Their work extends to patient protection and eco-sustainable solutions for everyday life, addressing the critical issue of antimicrobial resistance.
Based in Spokane, Washington, Iasis Molecular has pioneered and patented a family of technologies aimed at minimizing healthcare-acquired infections related to implantable medical devices, surgical procedures, and chronic wounds. Their proprietary antimicrobial agent technologies are designed to be cost-effective and accessible, potentially benefiting patients across diverse demographics and medical needs.
Companies similar to Iasis Molecular include Anti-Microbial Solutions, Iaso Pharma, Aionx Antimicrobial Technologies and Molecular Detection.
Iasis Molecular was founded in 2008.
Iasis Molecular's headquarters is located in Spokane, WA, US.
Iasis Molecular's most recent funding round was for $1.3M (USD) in January 2022.
As of Jan 25, 2022, Iasis Molecular has raised a total of $1.3M (USD).
Iasis Molecular has 3 employees as of Feb 4, 2024.
Aionx Antimicrobial Technologies
aionx.com
